Literature DB >> 12973483

Incidence and risk factors associated with the patency of ductus arteriosus in preterm infants with respiratory distress syndrome in Kuwait.

Majeda S Hammoud1, Hassan A Elsori, Emad-Aldeen M Hanafi, Adel A Shalabi, Ibrahim A Fouda, Lakshmi V Devarajan.   

Abstract

OBJECTIVE: Patent ductus arteriosus (PDA) is considered to be an important cause of morbidity and mortality among preterm infants. The aim of this study is to determine the incidence of PDA in ventilated preterm infants with respiratory distress syndrome (RDS) and to evaluate the role of some antenatal risk factors on its occurrence in our population.
METHODS: The case records of the preterm infants of <34 weeks gestational age, who were ventilated for RDS at the neonatal intensive care unit of Maternity Hospital, Safat, Kuwait, between March 1998 and February 1999, were reviewed. Diagnosis of PDA was based on echocardiographic findings. The association between the risk factors chosen and the PDA was also evaluated.
RESULTS: A total of 101 infants whose gestational ages ranged between 25-33 weeks, and birth weights between 685-1580 grams were included. Fifty-four had a significant PDA (53.4%). Maternal diabetes and antepartum hemorrhage (APH), birth weights, gestational ages, multiplicity and gender of the infants were found to be related to the incidence of PDA.
CONCLUSION: The incidence of PDA in our ventilated preterm infants with RDS is similar to those reported from other neonatal units outside Kuwait. There are some factors that may identify babies, who are prone to develop PDA, which need to be confirmed by further prospective studies using a larger population.

Entities:  

Mesh:

Year:  2003        PMID: 12973483

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


  5 in total

Review 1.  Inadvertent relaxation of the ductus arteriosus by pharmacologic agents that are commonly used in the neonatal period.

Authors:  Jeff Reese; Alex Veldman; Lisa Shah; Megan Vucovich; Robert B Cotton
Journal:  Semin Perinatol       Date:  2010-06       Impact factor: 3.300

2.  Factors affecting the effectiveness of oral ibuprofen in the treatment of patent ductus arteriosus in preterm infants.

Authors:  Chaohui Ye; Qin Lyu; Linyan Jiang; Li Yu; Yinquan Xu; Jie Zhang; Xiaodong Lu
Journal:  Int J Clin Pharm       Date:  2021-01-05

3.  [Effectiveness and safety of the surgical closure of permeable arteriosus conduct by the general pediatric surgeon: clinical trial].

Authors:  Antonio F Gallardo-Meza; José M González-Sánchez; Francisco Vidrio-Patrón; Irene L Velarde-Briceño; Alejandra Peña-Juárez; Humberto Murguía-Guerrero; María Teresa Martínez-González; Oscar E Ceja-Mejía; Miguel A Medina-Andrade; Paulina Armas-Quiroz; Brenda N Arias-Uribe; Elizabeth López-Villalobos; Humberto Vázquez-Jackson
Journal:  Arch Cardiol Mex       Date:  2021

Review 4.  Sex Differences in Patent Ductus Arteriosus Incidence and Response to Pharmacological Treatment in Preterm Infants: A Systematic Review, Meta-Analysis and Meta-Regression.

Authors:  Moreyba Borges-Lujan; Gema E Gonzalez-Luis; Tom Roosen; Maurice J Huizing; Eduardo Villamor
Journal:  J Pers Med       Date:  2022-07-14

5.  Persistent Ductus Arteriosus in Critically Ill Preterm Infants.

Authors:  Maria Livia Ognean; Oana Boantă; Simona Kovacs; Corina Zgârcea; Raluca Dumitra; Ecaterina Olariu; Doina Andreicuţ
Journal:  J Crit Care Med (Targu Mures)       Date:  2016-11-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.